Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
NCT06222437 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2026-03-23
Summary
The purpose of this study is to investigate the effect of semaglutide in women with Polycystic Ovarian Syndrome(PCOS ) and determine potential therapeutic benefits.
Conditions
- Polycystic Ovary Syndrome
Interventions
- DRUG
-
effectiveness of semaglutide in PCOS
Sponsors & Collaborators
-
Methodist Health System
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-28
- Primary Completion
- 2026-02-28
- Completion
- 2027-02-28
- FDA Drug
- Yes
More Related Trials
-
GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)
NCT04876027 ·Status: COMPLETED ·Phase: PHASE4
-
Chiglitazar/Metformin in Non-obese Women With PCOS
NCT06125587 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
SGLT2 Inhibitors in Treating Patients With PCOS
NCT05966792 ·Status: COMPLETED ·Phase: NA
-
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
NCT03919929 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
NCT03151005 ·Status: COMPLETED ·Phase: PHASE4
-
Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin
NCT01911468 ·Status: COMPLETED ·Phase: PHASE4
-
Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility
NCT05952882 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
SGLT2 Inhibitors in Patients With PCOS
NCT04700839 ·Status: COMPLETED ·Phase: PHASE4
-
A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
NCT07326111 ·Status: RECRUITING ·Phase: PHASE4
-
Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM
NCT05760677 ·Status: UNKNOWN ·Phase: PHASE1
-
The Effect of a Liraglutide on IVF in Obese PCOS
NCT03353948 ·Status: COMPLETED ·Phase: PHASE4
-
Treating PCOS With Digital Intervention vs. Metformin
NCT05386706 ·Status: COMPLETED ·Phase: NA
-
LIPT - Liraglutide in Polycystic Ovary Syndrome
NCT02073929 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
NCT07169136 ·Status: RECRUITING
-
Effects of Metformin Plus Simvastatin on Polycystic Ovarian Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study
NCT01021579 ·Status: COMPLETED ·Phase: PHASE4
-
Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome
NCT02483299 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome
NCT00319293 ·Status: UNKNOWN ·Phase: NA
-
Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients
NCT01003483 ·Status: COMPLETED ·Phase: PHASE2
-
Short Term Weight Loss With Liraglutide and Metformin in Infertile Obese PCOS Patients
NCT03034941 ·Status: COMPLETED ·Phase: PHASE4
-
Myo-inositol Versus Metformin in Obese Women With Polycystic Ovary Syndrome
NCT01791647 ·Status: COMPLETED ·Phase: NA
-
Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS
NCT04257500 ·Status: COMPLETED ·Phase: PHASE4
-
Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity
NCT06140108 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
NCT06576375 ·Status: RECRUITING ·Phase: PHASE3
-
Polycystic Ovary Syndrome Genetics and Treatment Response
NCT01389778 ·Status: UNKNOWN ·Phase: NA
-
Dapagliflozin Efficacy and Action in PCOS
NCT04213677 ·Status: COMPLETED ·Phase: PHASE3